Voloridge Investment Management’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-98,331
Closed -$12.9M 1170
2024
Q4
$12.9M Sell
98,331
-125,878
-56% -$17.6M 0.05% 502
2024
Q3
$34.9M Buy
+224,209
New +$36.2M 0.13% 247
2024
Q2
Sell
-424,397
Closed -$57.5M 1199
2024
Q1
$57.5M Buy
424,397
+298,646
+237% +$39.5M 0.21% 132
2023
Q4
$16.9M Buy
125,751
+5,654
+5% +$735K 0.07% 360
2023
Q3
$16.3M Sell
120,097
-107,711
-47% -$14.7M 0.08% 331
2023
Q2
$32.6M Sell
227,808
-230,278
-50% -$33.9M 0.15% 185
2023
Q1
$63.6M Buy
458,086
+23,647
+5% +$3.18M 0.32% 66
2022
Q4
$58.9M Buy
434,439
+210,484
+94% +$26.4M 0.33% 61
2022
Q3
$24.6M Buy
223,955
+222,117
+12,085% +$28.2M 0.13% 219
2022
Q2
$243K Buy
+1,838
New +$241K ﹤0.01% 1365
2022
Q1
Sell
-26,746
Closed -$3.12M 1365
2021
Q4
$3.12M Buy
+26,746
New +$3.15M 0.02% 905
2021
Q2
Sell
-576,026
Closed -$57.3M 1604
2021
Q1
$57.3M Sell
576,026
-966,855
-63% -$97.2M 0.42% 43
2020
Q4
$154M Buy
+1,542,881
New +$163M 1.29% 7
2020
Q3
Sell
-103,846
Closed -$11M 1246
2020
Q2
$11M Buy
103,846
+21,602
+26% +$2.23M 0.13% 174
2020
Q1
$7.35M Sell
82,244
-106,702
-56% -$10M 0.21% 107
2019
Q4
$18.8M Buy
188,946
+19,346
+11% +$1.82M 0.37% 49
2019
Q3
$15.1M Buy
169,600
+56,267
+50% +$4.88M 0.26% 66
2019
Q2
$9.36M Buy
113,333
+36,420
+47% +$2.86M 0.26% 84
2019
Q1
$6.22M Sell
76,913
-31,302
-29% -$2.47M 0.19% 118
2018
Q4
$8.22M Buy
+108,215
New +$8.45M 0.37% 74
2018
Q3
Sell
-122,889
Closed -$8.63M 295
2018
Q2
$8.63M Sell
122,889
-79,984
-39% -$5.75M 0.23% 103
2018
Q1
$14.2M Buy
202,873
+112,422
+124% +$7.79M 0.33% 49
2017
Q4
$6.28M Buy
+90,451
New +$6.1M 0.14% 175
2017
Q3
Sell
-157,882
Closed -$10.8M 386
2017
Q2
$10.8M Buy
+157,882
New +$10.3M 0.27% 105
2016
Q2
Sell
-327,787
Closed -$18.5M 294
2016
Q1
$18.5M Buy
+327,787
New +$19.7M 0.43% 48

Other funds holding AZN